Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study
Mario Mandalà(University of Perugia), Paolo A. Ascierto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Marco Tucci(Prostate Cancer UK), Maria Grazia Vitale(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Ana Arance(Hospital Clínic de Barcelona), Joanna Placzke(The Maria Sklodowska-Curie National Research Institute of Oncology), Alexander M. Menzies(The University of Sydney), Barbara Merelli(Ospedale Papa Giovanni XXIII), Maria Chiara Sergi(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Michele Guida(Istituto Tumori Bari), Francesco Spagnolo(Martin University), Eva Muñoz‐Couselo(Vall d'Hebron Hospital Universitari), Ernesto Rossi(Agostino Gemelli University Polyclinic), Inês Pires da Silva(The University of Sydney), Pietro Quaglino(Department of Medical Sciences), Paul Lorigan(Manchester Academic Health Science Centre), Roberta Depenni(University of Modena and Reggio Emilia), Georgina V. Long(The University of Sydney), Paola Queirolo, Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), Marcella Occelli, Bart Neyns(Universitair Ziekenhuis Brussel), Naima Benannoune(Institut Gustave Roussy), Diana Giannarelli(Agostino Gemelli University Polyclinic), Caroline Robert(Institut Gustave Roussy), Patricio Serra(University of Manchester), Michele Del Vecchio(Fondazione IRCCS Istituto Nazionale dei Tumori), Anna Maria Di Giacomo(University of Siena), Alice Indini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 45
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.9k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
|New England Journal of Medicine|2013|3.4k